Breaking News
Just In
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ:REGN)

558.87 +13.41 (+2.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,656,808
Open 583.01
Bid (Size) 558.00 (1)
Ask (Size) 561.00 (1)
Prev. Close 545.46
Today's Range 542.89 - 583.28
52wk Range 476.49 - 1,211.20
Shares Outstanding 91,779,465
Dividend Yield 0.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Regeneron (REGN) Q2 EPS Jumps 53%
Via The Motley Fool
Stocks Sell Off, Gold Rallies On Tariff Turmoil, Weak Jobs Data: What's Moving Markets Friday?
It's a rough start to the new month for Wall Street, as major U.S. stock indices plunged by midday Friday, setting the stage for a negative weekly close. 
Via Benzinga

Performance

YTD
-21.9%
-21.9%
1 Month
+2.0%
+2.0%
3 Month
-7.7%
-7.7%
6 Month
-17.0%
-17.0%
1 Year
-48.9%
-48.9%

More News

Read More
Why Regeneron (REGN) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence
4D Molecular Therapeutics Rallies On Heels Of Diabetes-Related Vision Study
Via Benzinga
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
Via Benzinga
Regeneron Pharmaceuticals (NASDAQ:REGN) Beats Q2 2025 Earnings Estimates but Faces Muted Market Reaction
Via Chartmill
Topics Earnings
Regeneron’s (NASDAQ:REGN) Q2: Strong Sales
Via StockStory
Regeneron Reports Second Quarter 2025 Financial and Operating Results
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Exploring Regeneron Pharmaceuticals's Earnings Expectations
Via Benzinga
Earnings Scheduled For August 1, 2025
Via Benzinga
Regeneron (REGN) Q2 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence Government World Trade
2 Healthcare Stocks That Are Losing to the S&P 500 This Year
Via The Motley Fool
Topics Stocks
$1000 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
3 Low-Volatility Stocks We Steer Clear Of
Via StockStory
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
Via Benzinga
Topics Government
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
Via The Motley Fool
Topics Intellectual Property
How Is The Market Feeling About Regeneron Pharmaceuticals?
Via Benzinga
1 Healthcare Stock on Our Buy List and 2 to Brush Off
Via StockStory
Topics Stocks
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade
Assessing Regeneron Pharmaceuticals: Insights From 26 Financial Analysts
Via Benzinga
1 Cash-Heavy Stock to Own for Decades and 2 to Ignore
Via StockStory
23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA Privacy
Via Stocktwits
Topics Bankruptcy

Frequently Asked Questions

Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 558.87
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 08/01/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 51.29B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 51B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.